TrialClinical and translational science2024

The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers.

Stefan J Jodl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.